Citi analysts have taken action on two U.S. MedTech names, upgrading Haemonetics (NYSE: HAE) to Buy from Neutral, while downgrading Tandem Diabetes Care (NASDAQ: ...

Disney (NYSE: DIS) stands out with a strong content slate, a broader Hulu rollout, and progress on theme park expansion.

The sector’s defensive characteristics are also evident in the current macro backdrop. While medical devices are somewhat ...

Under the "current situation" scenario, the fundamental valuation range has been raised to 6,195–6,343, with a midpoint of 6,269, reflecting “the transition to expected 2026 earnings of $295/share,” ...